Martin Gaal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Martin Gaal has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Gregor Dörl
Functional Brain Diagnostics and Therapy, Department of Neurology, Medical University of Vienna, Spitalgasse 23, A-1090 Vienna, Austria
1 shared publication - Roland Beisteiner
Medical University of Vienna
1 shared publication - Sonja Radjenovic
Department of Public Mental Health, Center for Public Health, Medical University of Vienna, Vienna, Austria
1 shared publication
Latest Publications
- Open Access
- 22 September 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (10) , 1277
Safety of Clinical Ultrasound Neuromodulation
Transcranial ultrasound holds much potential as a safe, non-invasive modality for navigated neuromodulation, with low-intensity focused ultrasound (FUS) and transcranial pulse stimulation (TPS) representing the two main modalities. While neuroscientific and preclinical applications have received much interest, clinical applications are still relatively scarce. For safety considerations, the current literature is largely based on guidelines for ultrasound imaging that uses various physical parameters to describe the ultrasound pulse form and expected bioeffects. However, the safety situation for neuromodulation is inherently different. This article provides an overview of relevant ultrasound parameters with a focus on bioeffects relevant for safe clinical applications. Further, a retrospective analysis of safety data for clinical TPS applications in patients is presented.
- 22 September 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (10) , 1277
Open AccessSafety of Clinical Ultrasound Neuromodulation
Transcranial ultrasound holds much potential as a safe, non-invasive modality for navigated neuromodulation, with low-intensity focused ultrasound (FUS) and transcranial pulse stimulation (TPS) representing the two main modalities. While neuroscientific and preclinical applications have received much interest, clinical applications are still relatively scarce. For safety considerations, the current literature is largely based on guidelines for ultrasound imaging that uses various physical parameters to describe the ultrasound pulse form and expected bioeffects. However, the safety situation for neuromodulation is inherently different. This article provides an overview of relevant ultrasound parameters with a focus on bioeffects relevant for safe clinical applications. Further, a retrospective analysis of safety data for clinical TPS applications in patients is presented.